Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Faga Daniel Create: Alert

All | News | Filings
Date FiledTypeDescription
01/10/2023 4 Faga Daniel (Interim CEO) has filed a Form 4 on ANAPTYSBIO, INC
Txns: Granted 194,900 options to buy @ $23.23, valued at $4.5M
Granted 71,400 restricted stock units @ $0
03/23/2022 4 Faga Daniel (Interim CEO) has filed a Form 4 on ANAPTYSBIO, INC
Txns: Granted 887,043 shares @ $0
02/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2021 4 Faga Daniel (Director) has filed a Form 4 on ANAPTYSBIO, INC
Txns: Granted 11,000 options to buy @ $31.12, valued at $342.3k
Granted 2,321 options to buy @ $31.12, valued at $72.2k
11/30/2021 3 Faga Daniel (Director) has filed a Form 3 on ANAPTYSBIO, INC
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2020 4 Faga Daniel (EVP, COO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 26,240 shares @ $0
Granted 64,970 options to buy @ $114.33, valued at $7.4M
01/08/2020 3 Faga Daniel (EVP, COO) has filed a Form 3 on Mirati Therapeutics, Inc.
12/17/2019 4 Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Unknown transaction of 38,828 shares @ $114.5, valued at $4.4M
Disposed/sold 35,000 options to buy @ $42.73, valued at $1.5M
Disposed/sold 26,250 options to buy @ $50.55, valued at $1.3M
Disposed/sold 14,000 options to buy @ $56.17, valued at $786.4k
Disposed/sold 50,000 options to buy @ $37.62, valued at $1.9M
Disposed/sold 21,500 restricted stock units @ $0
03/27/2019 4 Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Paid exercise price by delivering 51,401 shares @ $113.42, valued at $5.8M
Paid exercise price by delivering 10,325 shares @ $113.43, valued at $1.2M
Paid exercise price by delivering 6,228 shares @ $113.43, valued at $706.4k
Exercised 80,000 options to buy @ $37.62, valued at $3M
Exercised 14,000 options to buy @ $56.17, valued at $786.4k
Exercised 8,750 options to buy @ $50.55, valued at $442.3k
01/23/2019 4 Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Paid exercise price by delivering 766 shares @ $45.08, valued at $34.5k
Paid exercise price by delivering 823 shares @ $45.08, valued at $37.1k
Exercised 2,000 restricted stock units @ $0
Exercised 2,500 restricted stock units @ $0
01/17/2019 4 Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $42.73, valued at $1.5M
Granted 10,000 restricted stock units @ $0
01/22/2018 4 Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Paid exercise price by delivering 879 shares @ $50.55, valued at $44.4k
Granted 35,000 options to buy @ $50.55, valued at $1.8M
Granted 10,000 restricted stock units @ $0
Exercised 2,000 restricted stock units @ $0
10/24/2017 4 Faga Daniel (Chief Business Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 6,000 shares @ $79.95, valued at $479.7k
Sold 1,500 shares @ $85, valued at $127.5k
Exercised 6,000 options to buy @ $37.62, valued at $225.7k
Exercised 1,500 options to buy @ $37.62, valued at $56.4k
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy